These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 24341007)

  • 1. [Evolution of treatment options for hypertension].
    Fursov AN; Potekhin NP; Orlov FA; Zakharova EG
    Voen Med Zh; 2013 Jul; 334(7):26-31. PubMed ID: 24341007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemplating the history of drug therapy for hypertension.
    Rosenthal T
    Blood Press; 2004; 13(5):262-71. PubMed ID: 15545148
    [No Abstract]   [Full Text] [Related]  

  • 3. Milestones in antihypertensive drug treatment.
    Tsoucalas G; Karamanou M; Vavuranakis M; Sgantzos M; Stefanadis C; Androutsos G
    Curr Pharm Des; 2015; 21(6):705-8. PubMed ID: 25341863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Scientific standards in parasitology in historical perspective].
    Lonc E; Płonka-Syroka B
    Wiad Parazytol; 2005; 51(3):197-207. PubMed ID: 16913523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Historical trends and milestones in hypertension research: a model of the process of translational research.
    Kotchen TA
    Hypertension; 2011 Oct; 58(4):522-38. PubMed ID: 21859967
    [No Abstract]   [Full Text] [Related]  

  • 6. A vaccine for hypertension.
    Ménard J
    J Hypertens; 2007 Jan; 25(1):41-6. PubMed ID: 17143170
    [No Abstract]   [Full Text] [Related]  

  • 7. Module 1: Historical review of evidence-based treatment of hypertension.
    White WB
    J Fam Pract; 2012 Aug; 61(8 Suppl):S5-14; quiz S27. PubMed ID: 22993740
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypertension and hypertensive encephalopathy.
    Price RS; Kasner SE
    Handb Clin Neurol; 2014; 119():161-7. PubMed ID: 24365295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fifty years history of new drugs in Japan: the developments and trends of antihypertensive drugs].
    Ozawa H
    Yakushigaku Zasshi; 2000; 35(1):63-71. PubMed ID: 11640208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is it time to celebrate a century of blood pressure management?
    Berend K; Levi M
    Nephrol Dial Transplant; 2008 Aug; 23(8):2558-62. PubMed ID: 18323522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cilnidipine: a new generation Ca channel blocker with inhibitory action on sympathetic neurotransmitter release.
    Takahara A
    Cardiovasc Ther; 2009; 27(2):124-39. PubMed ID: 19426250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [History of treatment of essential hypertension--part I].
    Widimský J
    Vnitr Lek; 2002 Jan; 48(1):62-70. PubMed ID: 11852592
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of arterial hypertension in obese patients.
    Wenzel UO; Benndorf R; Lange S
    Semin Nephrol; 2013 Jan; 33(1):66-74. PubMed ID: 23374895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Historical reflections on hypertension.
    Vertes V; Tobias L; Galvin S
    Prim Care; 1991 Sep; 18(3):471-82. PubMed ID: 1946783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 50 years of thiazides: should thiazide diuretics be considered third-line hypertension treatment?
    Brown A; Captain B
    Am J Ther; 2011 Nov; 18(6):e244-54. PubMed ID: 21436766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In memory of Professor John H. Laragh.
    Volpe M
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):197. PubMed ID: 25943779
    [No Abstract]   [Full Text] [Related]  

  • 18. John H. Laragh, MD: clinician-scientist.
    Sealey JE
    Am J Hypertens; 2014 Aug; 27(8):1019-23. PubMed ID: 25103936
    [No Abstract]   [Full Text] [Related]  

  • 19. Lessons in Uncertainty and Humility - Clinical Trials Involving Hypertension.
    Pfeffer MA; McMurray JJ
    N Engl J Med; 2016 Nov; 375(18):1756-1766. PubMed ID: 27806228
    [No Abstract]   [Full Text] [Related]  

  • 20. Historical evolution of angiotensin II receptor blockers: therapeutic advantages.
    Gavras H
    J Am Soc Nephrol; 1999 Apr; 10 Suppl 12():S255-7. PubMed ID: 10201879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.